Adicet Bio Prices Public Offering Of 27,054,667 Common Shares At $2.40/share, And Pre-Funded Warrants To Purchase 8,445,333 Common Shares At $2.3999/Pre-Funded Warrant
Author: Benzinga Newsdesk | January 23, 2024 03:18am
The gross proceeds from the offering, before deducting underwriting discounts and commissions and offering expenses, are expected to be approximately $85.2 million, excluding any exercise of the underwriters' option to purchase additional shares. All of the securities in the offering are to be sold by Adicet. The offering is expected to close on or about January 25, 2024, subject to customary closing conditions.
Posted In: ACET